Construction of GEA’s new pharmaceutical technology center in Elsdorf, Germany, begins today – setting new industry benchmarks. The machinery and plant manufacturer is investing EUR 80 million in the new freeze-drying systems facility. These systems are used in the production of numerous injectable pharmaceuticals, including vaccines. The new facility is scheduled to open in the second half of 2025.